These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34251311)

  • 61. Lung involvement in juvenile idiopathic inflammatory myopathy: A systematic review.
    Abu-Rumeileh S; Marrani E; Maniscalco V; Maccora I; Pagnini I; Mastrolia MV; Rouster-Stevens K; Simonini G
    Autoimmun Rev; 2023 Oct; 22(10):103416. PubMed ID: 37611886
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
    Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL
    Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies.
    Okiyama N; Fujimoto M
    F1000Res; 2019; 8():. PubMed ID: 31824645
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.
    Hamaguchi Y; Fujimoto M; Matsushita T; Kaji K; Komura K; Hasegawa M; Kodera M; Muroi E; Fujikawa K; Seishima M; Yamada H; Yamada R; Sato S; Takehara K; Kuwana M
    PLoS One; 2013; 8(4):e60442. PubMed ID: 23573256
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Raynaud's phenomenon and anti-nuclear antibody are associated with pulmonary function decline in patients with dermatomyositis and polymyositis.
    Park EH; Hwang WC; Lee Y; Lee EY; Lee EB; Song YW; Park JK
    Int J Rheum Dis; 2019 Mar; 22(3):507-515. PubMed ID: 30548402
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serological risk factors for concomitant interstitial lung disease in patients with idiopathic inflammatory myopathy.
    Huang HL; Lin WC; Yeh CC; Sun YT
    J Clin Neurosci; 2020 Apr; 74():32-35. PubMed ID: 31982271
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association of various myositis-specific autoantibodies with dermatomyositis and polymyositis triggered by pregnancy.
    Akiyama C; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
    Rheumatol Int; 2022 Jul; 42(7):1271-1280. PubMed ID: 33837447
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
    Wang PZ; Guan JL; Han XH
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
    Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N;
    J Autoimmun; 2019 Jul; 101():48-55. PubMed ID: 30992170
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
    Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T
    Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
    Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
    Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease.
    Kaieda S; Gono T; Masui K; Nishina N; Sato S; Kuwana M;
    PLoS One; 2020; 15(6):e0234523. PubMed ID: 32525903
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical value of cancer-associated myositis-specific antibodies, anti-transcriptional intermediary factor 1-γ, and anti-nuclear matrix protein 2 antibodies in a retrospective cohort of dermatomyositis/polymyositis in a Japanese community hospital.
    Suga T; Oiwa H; Ishida M; Iwamoto Y
    Clin Rheumatol; 2022 Sep; 41(9):2803-2808. PubMed ID: 35399148
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.
    Ikeda S; Arita M; Misaki K; Mishima S; Takaiwa T; Nishiyama A; Ito A; Furuta K; Yokoyama T; Tokioka F; Noyama M; Yoshioka H; Ishida T
    Springerplus; 2015; 4():240. PubMed ID: 26101728
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions.
    Hirakata M
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):444-54. PubMed ID: 18174673
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pulmonary manifestations of polymyositis/dermatomyositis.
    Hallowell RW; Ascherman DP; Danoff SK
    Semin Respir Crit Care Med; 2014 Apr; 35(2):239-48. PubMed ID: 24668538
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
    Sato S; Murakami A; Kuwajima A; Takehara K; Mimori T; Kawakami A; Mishima M; Suda T; Seishima M; Fujimoto M; Kuwana M
    PLoS One; 2016; 11(4):e0154285. PubMed ID: 27115353
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The analysis of clinical phenotypes and autoantibodies in juvenile dermatomyositis].
    Li DM; Wang L; Liu MY; Xu L; Tang XM
    Zhonghua Er Ke Za Zhi; 2020 Dec; 58(12):966-972. PubMed ID: 33256317
    [No Abstract]   [Full Text] [Related]  

  • 79. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literature.
    Ingegnoli F; Lubatti C; Ingegnoli A; Boracchi P; Zeni S; Meroni PL
    Autoimmun Rev; 2012 Mar; 11(5):335-40. PubMed ID: 21985773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.